Simple Summary
Dairy cows with high body condition scores are vulnerable to metabolic stress, inflammation, and disease around calving. We evaluated whether a single injection of meloxicam 14 days before expected calving influenced health indicators and gene activity in the liver and subcutaneous fat. Seventy-two cows were followed for postpartum health, reproduction, and milk production, and 12 of these cows underwent repeated blood sampling and tissue biopsy. The meloxicam group had fewer recorded postpartum disease events and a higher proportion of cows pregnant by 120 days, while milk yield was similar between groups; these clinical observations were descriptive and require confirmation. Blood-marker patterns differed over time between treatments for five of six measured biomarkers. Gene-expression differences between groups at 5 days after calving were limited, but changes from before to after calving involved genes related to liver inflammation and immune defense in adipose tissue. The results suggest that prepartum meloxicam may influence inflammatory and immune adaptation during the transition period, although larger studies are needed to establish its effects on health and reproduction.
Abstract
Periparturient dairy cows with high body condition scores are susceptible to metabolic stress and inflammation. This study evaluated whether a single prepartum dose of meloxicam modifies systemic biomarkers and liver and subcutaneous white adipose tissue (sWAT) transcriptomes. Seventy-two Holstein cows were assigned to control or meloxicam groups (36/group); meloxicam (0.5 mg/kg) or saline was administered subcutaneously 14 ± 1 days before expected calving. Twelve cows (6/group) underwent longitudinal blood sampling and prepartum and postpartum tissue biopsy. Postpartum disease, culling, pregnancy, and milk-yield outcomes were summarized descriptively. Treatment × time interactions were detected for non-esterified fatty acids, aspartate aminotransferase, serum amyloid A, haptoglobin, and insulin, but not γ-glutamyl transferase. Direct postpartum comparisons identified only five differentially expressed genes in each tissue. Within-group prepartum-to-postpartum comparisons identified 116 liver and 808 sWAT genes meeting differential expression criteria in the meloxicam but not the control group. Enriched functions included regulation of monocyte chemotaxis in the liver and respiratory burst, B-cell receptor, Toll-like receptor, and natural killer cell signaling in sWAT. Descriptively, meloxicam-treated cows had fewer postpartum disease events and a higher pregnancy proportion, with similar milk yield. These findings suggest that prepartum meloxicam may modify inflammatory and innate immune adaptation during the transition period; adequately powered studies are needed to confirm the clinical outcomes.
1. Introduction
Periparturient dairy cows are particularly vulnerable to disease because of impaired immune function and heightened inflammatory activity, both of which are closely linked to metabolic disruptions arising from a negative energy balance (NEB). This deficit is often more pronounced during the transition period in cows with high body condition scores (BCS) and stimulates extensive lipid mobilization from adipose stores, thereby substantially elevating plasma non-esterified fatty acid (NEFA) levels [1,2]. The resulting influx of NEFA into the liver may exceed its oxidative capacity, favoring ketogenesis. β-Hydroxybutyrate (BHBA), one of the principal products of this process, has been shown to activate pro-inflammatory responses in hepatocytes of bovine origin [3]. Moreover, a mild systemic inflammatory state commonly develops in dairy cows within the first seven days postpartum [4]. Although moderate inflammation may support metabolic and physiological adaptation [5], excessive inflammation reduces dry matter intake (DMI) [6], worsens metabolic disorders, and contributes to periparturient diseases and impaired lactation performance. Elevated NEFA and BHBA suppress the phagocytic and bactericidal activities of immune cells, impair pathogen clearance, and disrupt immune cell metabolism [7,8]. Excessive lipolysis also suppresses circulating monocyte function [9], while hepatic NEFA deposition increases metabolic pressure and may cause fatty liver [10]. Hepatic triglyceride (TG) accumulation has also been reported to impair neutrophil function and decrease circulating monocyte numbers [11]. Furthermore, transcriptomic analysis of neutrophils has demonstrated that increased plasma NEFA, BHBA, and hepatic TG concentrations suppress granulocyte recruitment, interferon (IFN) signaling, and apoptosis, thereby impairing neutrophil function [12]. Additional transcriptomic studies have shown that NEB suppresses biological processes related to humoral immunity in the uterus, liver, and blood, including cytokine production, immunoglobulin synthesis, and B-cell activation, suggesting a state of immunosuppression in transition dairy cows [13]. Systemic inflammation not only impairs liver function but also reduces immune competence during the periparturient period. Therefore, dairy cows with high BCS frequently experience severe NEB, which promotes both immunosuppression and inflammatory responses. The reciprocal interaction between these two pathological conditions further increases susceptibility to infections, including metritis, endometritis, and mastitis. The incidence of these postpartum diseases ranges from approximately 14% to 40% and substantially impairs both the economic performance of dairy farming and the well-being of affected animals [14,15,16]. Therefore, controlling inflammation and improving immune function are essential for supporting a successful transition in dairy cows with high BCS. Owing to their ability to alleviate inflammation and pain, non-steroidal anti-inflammatory drugs (NSAIDs) serve as valuable supportive therapeutic agents in dairy cattle production [17,18]. Meloxicam (MEL), an oxicam-class NSAID, exerts strong anti-inflammatory and analgesic effects with relatively limited gastrointestinal and renal adverse effects [19]. In 2013, oral MEL (Metacam®) was approved for pain management during calf dehorning when combined with local anesthesia. In addition to reducing post-dehorning pain [18,20], MEL has been reported to improve average daily gain in calves after weaning [21]. In dairy cows, MEL has been widely applied to alleviate inflammatory responses associated with infectious diseases, including metritis, endometritis, and mastitis [22,23,24], and has also been shown to improve milk production [25]. To date, experimental work on MEL under in vivo and in vitro conditions has mainly focused on inflammatory responses in the mammary gland and endometrium, whereas its regulatory effects on the liver tissue and subcutaneous white adipose tissue (sWAT), two critical metabolic organs involved in systemic inflammatory responses throughout the transition period, remain insufficiently understood. Accordingly, this study examined liver tissue and sWAT from periparturient dairy cows with high BCS, and transcriptome sequencing was used to characterize molecular and metabolic changes in these tissues across the interval spanning the prepartum and postpartum stages following subcutaneous administration of MEL before calving.
2. Materials and Methods
2.1. Animal Management
Seventy-two multiparous Holstein dairy cows with high BCS (≥3.5) were enrolled approximately 21 d before expected calving and randomly allocated equally to a control (CON) group (n = 36, BCS = 3.74 ± 0.15, 2–7 parities) and a MEL group (n = 36, 3.81 ± 0.11, 2–6 parities). No formal a priori sample size calculation was conducted in this study. The sample size of the main cohort was determined by the number of eligible dairy cows available throughout the research period. Cows assigned to the MEL group were administered a single subcutaneous dose of MEL (0.5 mg/kg body weight; Labiana Life Sciences S.A., Terrassa, Spain) 14 ± 1 d before expected calving, whereas CON cows received an equivalent volume of sterile 0.9% saline. Postpartum disease events diagnosed within 30 d after calving, culling within 60 d postpartum, pregnancy status by 120 d postpartum, and mean daily milk yield during the first 100 d of lactation were recorded (Supplementary Tables S1 and S2). These outcomes were summarized descriptively because the study was not adequately powered for inferential testing of clinical, reproductive, or culling outcomes. Six cows were randomly selected from each treatment group to form a 12-cow mechanistic subset, comprising six CON cows (BCS = 3.79 ± 0.04, 3–4 parities) and six MEL-treated cows (BCS = 3.79 ± 0.04, 3–4 parities). Baseline liver tissue and sWAT samples were collected from these 12 cows at 14 ± 1 d before expected calving, immediately before MEL or saline administration, and again on postpartum day 5. During the study, cows were offered a total mixed ration (TMR) at 07:00 and 19:00 each day, milked daily at 06:00, 12:00, and 18:00, and provided with unrestricted access to drinking water. The ingredient composition and chemical characteristics of the TMR are presented in Supplementary Table S17.
Postpartum diseases were diagnosed by the farm veterinarian. Metritis and endometritis were assessed by examination of vaginal discharge. Mastitis assessment included the California mastitis test (CMT), with clinical mastitis severity graded separately. Subclinical ketosis was diagnosed using blood BHBA testing (≥1.4 mmol/L), and left displaced abomasum by abdominal auscultation and percussion. Counts represent disease events rather than individual cows; a cow could contribute more than one event if different diseases were diagnosed within 30 d postpartum.
2.2. Determination of Serum Biochemical Parameters
Blood samples were collected from the 12 cows in the mechanistic subset at 14 ± 1 d before expected calving, immediately before MEL or saline administration, and again at 5 and 15 d postpartum. A 5 min centrifugation yielded serum for subsequent biochemical testing. Serum biomarkers, including insulin (INS; Beijing Laibotairui Technology Co., Ltd., Beijing, China, ELS592), serum amyloid A (SAA; Beijing Laibotairui Technology Co., Ltd., ELS648), γ-glutamyl transferase (GGT; Nanjing Jiancheng Bioengineering Institute, Nanjing, China, C017-2-1), aspartate aminotransferase (AST; Jiangsu Zecheng Biotechnology Co., Ltd., Jiangyin, China, IVD.WF.AST0002), haptoglobin (HP; Beijing Laibotairui Technology Co., Ltd., ELS643), and NEFA (Nanjing Jiancheng Bioengineering Institute, A042-2-1), were assessed with commercially available assay kits following the instructions of the manufacturers. Serum AST and GGT activities were expressed in U/L, whereas NEFA, SAA, HP, and INS were reported as concentrations. Individual biomarker data are provided in Supplementary Table S3.
2.3. Tissue Biopsy
Liver tissue and sWAT biopsy samples were collected and stored following the protocol described by Guo et al. [26]. For each experimental cow, liver biopsy was performed before sWAT biopsy. In prepartum cows, 50 mg progesterone was given by intramuscular injection immediately after local anesthesia to decrease the risk of premature parturition. All procedures were carried out carefully to reduce stress in the animals.
2.4. Ribonucleic Acid (RNA) Extraction and Quality Assessment
Total RNA was isolated from liver tissue and sWAT with TRIzol reagent (Invitrogen, Carlsbad, CA, USA) in accordance with the protocol. The concentration and purity of RNA were measured with a NanoDrop (NanoDrop Technologies, Wilmington, DE, USA), whereas RNA integrity was examined using a Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA, USA), with further confirmation by agarose gel electrophoresis. Only samples meeting all of the following requirements were used for RNA sequencing (RNA-seq): concentration > 50 ng/μL, RNA integrity number (RIN) > 7.0, a ratio of optical density at 260 nm to that at 280 nm (OD260/OD280) > 1.8, and total RNA yield > 1 μg.
2.5. Library Preparation
Poly(A)-enriched messenger RNA (mRNA) was obtained from total RNA through two successive rounds of purification with oligo(dT) magnetic beads (cat. no. 25-61005, Thermo Fisher Scientific, Waltham, MA, USA). The purified mRNA was fragmented with the NEBNext® Magnesium RNA Fragmentation Module (cat. no. E6150S, New England Biolabs, Ipswich, MA, USA) at 94 °C for 5–7 min. First-strand complementary deoxyribonucleic acid (cDNA) was generated from the resulting fragments using SuperScript™ II Reverse Transcriptase (cat. no. 1896649, Invitrogen, Carlsbad, CA, USA). Second-strand synthesis was performed with Escherichia coli deoxyribonucleic acid (DNA) polymerase I (cat. no. M0209, New England Biolabs, Ipswich, MA, USA) and ribonuclease H (RNase H) (cat. no. M0297, New England Biolabs, Ipswich, MA, USA), incorporating deoxyuridine triphosphate (dUTP) solution (cat. no. R0133, Thermo Fisher Scientific, Waltham, MA, USA) into the newly synthesized strand. The double-stranded cDNA underwent blunt-end repair followed by the addition of a single adenine nucleotide to each 3′ end, enabling ligation to thymine-tailed adapters. Adapter-ligated products were size-selected and purified with magnetic beads, after which the dUTP-containing strand was digested using uracil-DNA glycosylase (UDG; cat. no. M0280, New England Biolabs, Ipswich, MA, USA). Library amplification was conducted at 95 °C for 3 min, followed by eight cycles of 98 °C for 15 s, 60 °C for 15 s, and 72 °C for 30 s, with a final extension at 72 °C for 5 min. The resulting libraries had a mean fragment size of 300 ± 50 base pairs (bp). After quality control, paired-end 150 bp sequencing was performed on an Illumina NovaSeq™ 6000 platform by LC Bio Technology Co., Ltd. (San Diego, CA, USA) in accordance with the manufacturer’s standard protocol.
2.6. Data Quality Control
Data quality was assessed as described by Guo et al. [26]. Raw RNA-seq data are available in the National Genomics Data Center (NGDC) Genome Sequence Archive (GSA) under accession CRA045141 (https://ngdc.cncb.ac.cn/gsa, accessed on 12 November 2026). Sequencing quality-control statistics are provided in Supplementary Table S5.
2.7. Read Mapping to the Reference Genome
High-quality clean sequences from all samples were mapped against the cattle genome assembly ARS-UCD1.2 with HISAT2 version 2.2.1 [27]. The mean mapping efficiency across the samples exceeded 95% (Supplementary Table S6).
2.8. Differential Expression and Functional Enrichment Analyses
StringTie (v2.1.6) was used to reconstruct transcript models independently for each sample with the default parameters [28]. Transcript assemblies generated across the complete sample set were then consolidated with gffcompare (v0.9.8) to produce a unified transcriptome annotation [29]. StringTie and Ballgown (Version: v2.42.0) were used to quantify transcript abundance. Fragments Per Kilobase of transcript per Million mapped reads (FPKM) values were used only for descriptive visualization, whereas a gene-level raw count matrix derived from the StringTie output was used as input for differential expression analysis with DESeq2 [30]. Pairwise comparisons were performed among prepartum liver (PPRE_L_C) and adipose tissue (PPRE_A_C) from cows assigned to the CON group, prepartum liver (PPRE_L_M) and adipose tissue (PPRE_A_M) from cows assigned to the MEL group, postpartum CON liver (PP_L_C), postpartum CON adipose tissue (PP_A_C), postpartum MEL-treated liver (PP_L_M), and postpartum MEL-treated adipose tissue (PP_A_M) groups. Differential expression analyses were conducted separately for each tissue and comparison. Differentially expressed genes (DEGs) were identified using a false discovery rate (FDR)-adjusted p-value (Q) < 0.05 and an absolute fold change (|FC|) ≥ 2 as the significance criteria. For each tissue, Venn diagrams were used to compare the DEG sets from the separate prepartum-to-postpartum comparisons in CON and MEL cows. Genes meeting the differential expression criteria in the MEL comparison but not in the CON comparison were selected for exploratory functional enrichment analysis. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed using clusterProfiler (v4.18.4). p-values were adjusted using the Benjamini–Hochberg procedure, and terms with Q < 0.05 were considered significantly enriched.
2.9. Validation of DEGs by Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR)
To confirm the RNA-seq findings, RT-qPCR was used to quantify dual specificity phosphatase 1 (DUSP1), cellular communication network factor 3 (CCN3), and insulin-like growth factor 1 (IGF1) transcripts in liver tissue and neutrophil cytosolic factor 4 (NCF4), neutrophil cytosolic factor 2 (NCF2), cytochrome b-245 beta chain (CYBB), and cytochrome b-245 alpha chain (CYBA) transcripts in sWAT. Measurements were performed in triplicate for every sample. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and ribosomal protein S9 (RPS9) served as the reference genes for sWAT and liver tissue, respectively, based on previous reports of stable expression in these tissues [31,32]. Reference-gene stability was not evaluated in the present dataset using geNorm, NormFinder, BestKeeper, or equivalent methods. Relative transcript abundance was derived with the cycle threshold (Ct)-based 2–ΔΔCt approach. Amplification efficiencies of the target and reference gene assays were not experimentally determined in this study. The corresponding primer sequences are listed in Supplementary Table S4.
2.10. Statistical Analysis
Technical triplicate measurements were averaged for each biological sample. Spearman’s rank correlation between RNA-seq and RT-qPCR log2 fold-change estimates was calculated across seven selected genes (n = 7 gene-level pairs, rather than individual cows or technical replicates) using IBM SPSS Statistics 32.0 (IBM Corp., Armonk, NY, USA). Blood biomarkers were analyzed separately in R (v4.5.2) using type-III two-way repeated-measures analysis of variance (ANOVA), with treatment as the between-subject factor, sampling time as the within-subject factor, and individual cow as the repeated-measures subject. The model included treatment, time, and the treatment × time interaction. Geisser–Greenhouse-corrected p-values were reported for the time and treatment × time effects. Šídák-adjusted comparisons were used to compare the CON and MEL groups at each sampling time. The Benjamini–Hochberg procedure was applied across the six treatment × time interaction tests, with FDR-adjusted p-values reported as Q. Data are presented as the mean ± standard error of the mean (SEM). Statistical significance was defined as Q < 0.05 for FDR-controlled analyses and p < 0.05 for other tests, using the corrections described above where applicable. Principal component analysis (PCA) and visualization of DEGs were performed in R using ggplot2 version 4.0.3. Venn diagrams were generated using VennDiagram (v1.8.2).
3. Results
3.1. Effects of MEL on Reproductive Performance, Disease Incidence, and Production Performance
In the full cohort of 72 cows (36 per group), seven postpartum disease events were recorded within 30 d after calving in the CON group (two cases of endometritis/metritis, three of mastitis, one of ketosis, and one of milk fever), compared with three events in two MEL cows (one case each of endometritis/metritis, retained placenta, and displaced abomasum) (Table 1). Neither group experienced birth canal injury. No cows were culled in either group within 60 d postpartum. Pregnancy by 120 d postpartum was numerically higher in MEL than CON cows (77.78% vs. 55.56%), while average daily milk yield during the first 100 d postpartum was similar (49.71 ± 1.40 vs. 49.89 ± 1.69 kg/d). Because these outcomes were summarized descriptively without inferential statistical testing, the observed numerical differences should be considered exploratory and do not establish an effect of MEL on postpartum disease occurrence, reproductive performance, or milk yield. Confirmation in a larger, adequately powered study is needed.
Table 1.
Effects of MEL on Reproductive Performance, Disease Incidence, and Production Performance in Dairy Cows.
3.2. Effects of MEL on Liver Function, Inflammatory Markers, and Glucose Metabolism
To assess MEL-associated changes in inflammation and immunometabolic responses during the periparturient period, serum concentrations of NEFA, SAA, HP, and INS and activities of AST and GGT were determined in the 12-cow mechanistic subset (six cows per group) (Figure 1). Significant treatment × time interactions were detected for NEFA (p = 0.024, Q = 0.029; Figure 1A), AST (p = 0.018, Q = 0.027; Figure 1B), SAA (p = 0.016, Q = 0.027; Figure 1D), HP (p < 0.001, Q = 0.003; Figure 1E), and INS (p = 0.009, Q = 0.027; Figure 1F), indicating that their temporal profiles differed between the CON and MEL groups. No significant treatment × time interaction was detected for GGT (p = 0.158, Q = 0.158; Figure 1C). Neither the treatment-group main effect nor the time main effect was significant for any of the six biomarkers (all p > 0.05). From the prepartum sampling point to 5 d postpartum, mean NEFA concentration increased from 0.421 to 0.553 mmol/L in the CON group but decreased from 0.477 to 0.412 mmol/L in the MEL group. Mean AST activity increased from 86.392 to 92.054 U/L in the CON group but decreased from 93.579 to 82.071 U/L in the MEL group. Similarly, mean SAA concentration increased numerically from 2.240 to 2.325 μg/mL in the CON group but decreased from 2.418 to 2.113 μg/mL in the MEL group, whereas mean HP concentration increased numerically from 62.695 to 72.230 ng/mL in the CON group but decreased from 71.812 to 62.002 ng/mL in the MEL group. Mean INS concentration decreased from 6.078 to 5.847 mIU/L in the CON group but increased from 5.812 to 6.350 mIU/L in the MEL group. Despite the significant treatment × time interactions, Šídák-adjusted comparisons detected no between-group differences in SAA or HP at any sampling time. No time-specific between-group differences were detected for AST, GGT, or INS either. NEFA concentration was lower in MEL than CON cows at 5 d postpartum (Šídák-adjusted p = 0.040), but not at the other sampling times. By 15 d postpartum, the mean values in the MEL group had moved toward their respective prepartum levels, and no significant between-group differences were detected for any of the six biomarkers at this time point.
Figure 1.
Serum biomarkers in dairy cows treated with MEL or saline (CON): (A) NEFA, (B) AST, (C) GGT, (D) SAA, (E) HP, and (F) INS. AST and GGT are expressed as enzyme activities; the other biomarkers are expressed as concentrations. “−14 d” denotes sampling at 14 ± 1 d before expected calving and before treatment; “5 d” and “15 d” denote days postpartum. Small symbols represent individual cows, and large symbols connected by lines indicate group means ± SEM (n = 6 cows per group). Statistical boxes show p-values for the treatment × time interaction (T × G), time main effect (Time), and treatment-group main effect (Group), together with Benjamini–Hochberg-adjusted Q-values for the six interaction tests. p-values involving time were corrected using the Geisser–Greenhouse method. An asterisk (*) indicates a between-group difference at the same sampling time after Šídák adjustment (p < 0.05).
3.3. Baseline Validation of Transcriptomic Profiles Before MEL Administration
All transcriptomic analyses reported below were performed in the same 12-cow mechanistic subset (six cows per group). To verify that the physiological condition of the experimental animals was comparable before treatment, differential gene expression analyses were performed between the prepartum CON and prepartum MEL groups for both liver tissue and sWAT (PPRE_L_C vs. PPRE_L_M and PPRE_A_C vs. PPRE_A_M, respectively). Only 15 DEGs were found between the liver tissues of the two prepartum groups (PPRE_L_C vs. PPRE_L_M; Figure 2A). Similarly, only 29 DEGs were identified between the sWAT samples of the two groups (PPRE_A_C vs. PPRE_A_M) (Figure 2D; Supplementary Table S7). FDR-significant GO terms in both tissues contained no more than three DEGs, whereas no KEGG pathway met the Q < 0.05 threshold (Figure 2B,C,E,F; Supplementary Tables S8 and S9). These comparisons identified a limited number of baseline DEGs but do not rule out pre-existing individual variation.
Figure 2.
Differential gene expression and functional enrichment in liver tissue and sWAT comparing the prepartum MEL and CON groups. PPRE_L_C, prepartum CON liver; PPRE_L_M, prepartum liver from cows assigned to MEL; PPRE_A_C, prepartum CON sWAT; PPRE_A_M, prepartum sWAT from cows assigned to MEL. (A,D) Volcano plots for liver and sWAT, respectively. The horizontal axis shows log2 fold change, and the vertical axis shows −log10(Q-value); gray dashed lines mark the DEG identification thresholds (Q < 0.05 and |log2 fold change| ≥ 1). (B,E) GO enrichment plots for liver and sWAT DEGs, respectively. The horizontal axis shows the Z-score, and the vertical axis shows −log10(Q-value). Gray dashed horizontal lines indicate Q = 0.05 and Q = 0.01. Bubble size represents the DEG count, colors denote GO categories, and representative terms are labeled. (C,F) KEGG pathway summaries for liver and sWAT DEGs, respectively. Bar lengths represent DEG counts, pathway names are listed vertically, and colors denote KEGG functional categories. These KEGG pathways are displayed descriptively; none met Q < 0.05. Throughout the figure, Q denotes the FDR-adjusted p-value.
3.4. Differential Gene Expression in Postpartum Liver Tissue
PCA showed notable overlap between the confidence intervals of the postpartum MEL and CON liver samples, with no obvious separation in the overall transcriptomic profiles between the two groups (Figure 3A). In agreement with the PCA results, only five DEGs were detected between the postpartum CON and MEL-treated liver groups (PP_L_C vs. PP_L_M), including four upregulated and one downregulated gene (Figure 3B; Supplementary Table S10). Although GO and KEGG enrichment analyses identified several enriched biological processes and pathways (Figure 3C–F), each enriched term contained only one DEG (Supplementary Table S11), suggesting limited biological importance. Overall, these findings indicate that the transcriptomic profiles of postpartum liver tissue were highly similar between the MEL-treated and CON groups. Therefore, MEL showed little detectable effect on liver gene expression at 5 days postpartum.
Figure 3.
Differential gene expression and functional enrichment analyses of postpartum liver tissue between the MEL and CON groups. PP_L_C, postpartum CON liver; PP_L_M, postpartum MEL-treated liver. (A) PCA of RNA-seq data from postpartum liver tissue. (B) Volcano plot comparing PP_L_C with PP_L_M. The horizontal axis shows log2 fold change, and the vertical axis shows −log10(Q-value); gray dashed lines mark the DEG identification thresholds (Q < 0.05 and |log2 fold change| ≥ 1). (C,E) GO and KEGG enrichment scatterplots, respectively. The horizontal axis shows the rich factor, and the vertical axis lists GO terms or KEGG pathways. Bubble size represents the DEG count, and color indicates Q. (D,F) GO and KEGG bar plots, respectively, showing DEG counts and the distribution of upregulated (red) and downregulated (blue) genes among the displayed terms or pathways. Q denotes the FDR-adjusted p-value, with Q < 0.05 considered significant.
3.5. Differential Gene Expression in Postpartum sWAT
Similar to the results observed in liver tissue, PCA showed substantial overlap between the confidence intervals of the postpartum MEL and CON sWAT samples, with no clear separation in the overall transcriptomic profiles between the two groups (Figure 4A). Consistent with the PCA findings, only five DEGs were identified between the postpartum CON and MEL-treated adipose tissue groups (PP_A_C vs. PP_A_M), including two upregulated and three downregulated genes (Figure 4B; Supplementary Table S10). Although GO and KEGG enrichment analyses detected several enriched biological processes and pathways (Figure 4C–F), most enriched terms contained only one DEG, while only a few pathways contained two DEGs (Supplementary Table S12), indicating limited biological importance. In general, these findings show that the transcriptomic profiles of postpartum sWAT were highly comparable between the MEL-treated and CON groups. Accordingly, MEL had little detectable effect on the sWAT transcriptome at 5 days postpartum.
Figure 4.
Differential gene expression and functional enrichment analyses of postpartum sWAT between the MEL and CON groups. PP_A_C, postpartum CON sWAT; PP_A_M, postpartum MEL-treated sWAT. (A) PCA of RNA-seq data from postpartum sWAT. (B) Volcano plot comparing PP_A_C with PP_A_M. The horizontal axis shows log2 fold change, and the vertical axis shows −log10(Q-value); gray dashed lines mark the DEG identification thresholds (Q < 0.05 and |log2 fold change| ≥ 1). (C,E) GO and KEGG enrichment scatterplots, respectively. The horizontal axis shows the rich factor, and the vertical axis lists GO terms or KEGG pathways. Bubble size represents the DEG count, and color indicates Q. (D,F) GO and KEGG bar plots, respectively, showing DEG counts and the distribution of upregulated (red) and downregulated (blue) genes among the displayed terms or pathways. Q denotes the FDR-adjusted p-value, with Q < 0.05 considered significant.
3.6. Liver Transcriptomic Changes During the Transition Period
As shown in Figure 5A, correlations among biological replicates within each group were consistently higher than those observed between groups. In particular, the correlation between the CON and MEL groups was markedly lower than the within-group correlations, indicating good reproducibility of the RNA-seq data. PCA suggested a shift in liver transcriptomic profiles between the prepartum (PPRE) and postpartum (PP) stages along principal component 1 (PC1), although the sample distributions overlapped (Figure 5B). Considerable overlap was also observed between CON and MEL samples within each stage; PCA alone therefore does not establish a treatment effect. Venn analysis compared DEGs from the separate within-group prepartum-to-postpartum comparisons. Under the specified differential expression criteria, 116 DEGs were identified only in the MEL comparison and 94 only in the CON comparison (Figure 5C; Supplementary Table S13). Functional enrichment analysis of the 116 genes identified three GO terms meeting Q < 0.05: negative regulation of monocyte chemotaxis (Q = 0.0123), positive regulation of epithelial cell proliferation (Q = 0.0267), and otic vesicle formation (Q = 0.0406) (Figure 5D; Supplementary Table S14). KEGG analysis showed enrichment of pathways including the nuclear factor kappa B (NF-κB), mitogen-activated protein kinase (MAPK), p53, peroxisome proliferator-activated receptor (PPAR) signaling pathway, as well as inflammatory mediator regulation of transient receptor potential (TRP) channels; however, no KEGG pathway met Q < 0.05 (Figure 5F; Supplementary Table S14). Sankey diagrams further illustrated the relationships between representative DEGs, including CCN3 and DUSP1, and the selected GO terms and KEGG pathways (Figure 5E,G).
Figure 5.
Differential gene expression and functional enrichment analyses of liver tissue during the transition period in the MEL and CON groups. PPRE_L_C, prepartum CON liver; PPRE_L_M, prepartum liver from cows assigned to MEL; PP_L_C, postpartum CON liver; PP_L_M, postpartum MEL-treated liver. (A) Pearson correlation heatmap of RNA-seq samples from the four liver tissue groups (PPRE_L_C, PPRE_L_M, PP_L_C, and PP_L_M). (B) PCA of RNA-seq data from liver tissue. Samples were grouped as PPRE_L_C, PPRE_L_M, PP_L_C, and PP_L_M based on normalized and filtered gene expression data. (C) Venn diagram showing the overlap of DEGs identified in the comparisons of PP_L_C vs. PPRE_L_C and PP_L_M vs. PPRE_L_M. (D) GO enrichment analysis of DEGs identified only in the MEL within-group longitudinal comparison. In the GO scatterplot, the horizontal axis shows the rich factor, and the vertical axis lists GO terms. Dot size represents the number of DEGs associated with each GO term, and dot color indicates the Q-value. (E) Sankey diagram illustrating the associations between DEGs and enriched GO terms. DEGs are shown on the left, enriched GO terms are displayed in the center, and the bubble plot on the right summarizes the enrichment results. Bubble size represents the number of genes associated with each GO term, and bubble color indicates the Q-value. (F) KEGG pathway enrichment analysis of the same DEG set. In the KEGG scatterplot, the horizontal axis shows the rich factor, and the vertical axis lists pathways. Dot size represents the number of DEGs enriched in each pathway, and dot color indicates the Q-value. (G) Sankey diagram illustrating the associations between representative DEGs and selected KEGG pathways. Representative DEGs are shown on the left, enriched KEGG pathways are displayed in the center, and the bubble plot on the right summarizes the enrichment results. The gene count for each pathway is encoded by bubble size, whereas color maps the Q-value. No KEGG pathway met Q < 0.05.
3.7. sWAT Transcriptomic Changes During the Transition Period
Similar to the liver, the Pearson correlation heatmap showed that biological replicates within each sWAT group exhibited substantially higher correlation coefficients than samples from different groups, indicating good reproducibility of the RNA-seq data (Figure 6A). PCA of sWAT samples showed partial separation between the prepartum and postpartum time points along PC1, although the distributions overlapped. No clear separation between the CON and MEL groups was observed at either time point (Figure 6B). This pattern suggests that physiological stage may contribute to transcriptomic variation, but PCA alone does not establish an effect of MEL treatment. Venn analysis compared DEGs from the separate within-group prepartum-to-postpartum comparisons. A total of 1231 DEGs met the criteria only in the CON comparison and 808 only in the MEL comparison (Figure 6C; Supplementary Table S15). Functional enrichment analysis of the 808 genes revealed significant enrichment of GO terms primarily associated with immune responses, including respiratory burst, immune response, B-cell receptor signaling pathway, superoxide anion generation, response to bacterium, B-cell activation, Toll-like receptor signaling pathway, positive regulation of cytokine production, positive regulation of type II IFN production, reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex, lipopolysaccharide receptor complex, superoxide-generating reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H) oxidase activity, pattern recognition receptor activity, and Toll-like receptor binding (Figure 6D). KEGG pathway analysis likewise showed significant enrichment of immune-related pathways, including natural killer cell-mediated cytotoxicity, osteoclast differentiation, B-cell receptor signaling pathway, leukocyte transendothelial migration, Rap1 signaling pathway, chemokine signaling pathway, and complement and coagulation cascades (Figure 6F; Supplementary Table S16). Sankey diagrams further illustrated the relationships between representative DEGs, including CYBB, CYBA, neutrophil cytosolic factor 1 (NCF1), NCF2, NCF4, CD180 Molecule (CD180), Lymphocyte Antigen 96 (LY96), Toll Like Receptor 2 (TLR2), Unc-93 Homolog B1 (UNC93B1), Fc Receptor Like 1 (FCRL1), Complement Receptor Type 2 (CR2), Protein Kinase C Beta (PRKCB), and B Cell Scaffold Protein with Ankyrin Repeats 1 (BANK1), and the GO terms and KEGG pathways showing significant enrichment (Figure 6E,G).
Figure 6.
Differential gene expression and functional enrichment analyses of sWAT during the transition period in the MEL and CON groups. PPRE_A_C, prepartum CON sWAT; PPRE_A_M, prepartum sWAT from cows assigned to MEL; PP_A_C, postpartum CON sWAT; PP_A_M, postpartum MEL-treated sWAT. (A) Pearson correlation heatmap for RNA-seq samples from the four adipose tissue groups (PPRE_A_C, PPRE_A_M, PP_A_C, and PP_A_M). (B) PCA of RNA-seq data from sWAT. Samples were grouped as PPRE_A_C, PPRE_A_M, PP_A_C, and PP_A_M based on normalized and filtered expression profiles. (C) Venn diagram depicting shared DEGs between the PP_A_C vs. PPRE_A_C and PP_A_M vs. PPRE_A_M comparisons. (D,F) GO and KEGG enrichment analyses, respectively, of DEGs identified only in the MEL within-group longitudinal comparison. In both scatterplots, the horizontal axis shows the rich factor, and the vertical axis lists GO terms or KEGG pathways. Dot size denotes the number of associated DEGs, whereas color reflects the Q-value. (E,G) Sankey diagrams linking DEGs to enriched GO terms (E) and representative DEGs to enriched KEGG pathways (G). In both panels, genes are displayed on the left, enriched terms or pathways in the center, and bubble-based enrichment summaries on the right. Bubble size indicates the number of associated genes, and color denotes the Q-value. Q denotes the FDR-adjusted p-value, with Q < 0.05 considered significant.
3.8. RT-qPCR Validation of DEGs
To assess concordance for selected genes, transcript abundance was measured by RT-qPCR for three liver genes (DUSP1, CCN3, and IGF1) and four sWAT genes (NCF2, NCF4, CYBA, and CYBB). The seven gene-level pairs of log2 fold-change estimates showed complete rank concordance between RNA-seq and RT-qPCR (Spearman’s ρ = 1.0, p = 4 × 10−4; Figure 7). This comparison supports the selected-gene findings but does not assess individual-animal agreement or validate the transcriptome as a whole.
Figure 7.
Comparison of gene expression estimates obtained by RNA-seq and RT-qPCR. Each blue dot represents a pair of gene-level log2 fold-change estimates from the two methods (n = 7 selected genes). The red dashed line indicates the reference line (y = x), representing perfect agreement between the two methods. Comparison of RNA-seq with RT-qPCR by Spearman analysis yielded (ρ = 1.0, p = 4 × 10−4), indicating complete rank concordance.
4. Discussion
We examined prepartum-to-postpartum transcriptomic responses to MEL in the liver and sWAT of dairy cows with high BCS. Previous studies have shown that oral MEL suspension reduces the occurrence of subclinical mastitis, increases feed intake and milk production, and alleviates systemic inflammation in dairy cows [33]. In the present study, fewer postpartum disease events were recorded in MEL than CON cows, while mean daily milk yield was similar between groups. Pregnancy by 120 d postpartum was numerically higher in the MEL group, whereas no cows were culled in either group within 60 d postpartum. These descriptive observations are exploratory and do not establish an effect of MEL on postpartum disease occurrence, reproductive performance, culling, or milk yield. Larger, adequately powered studies are needed to assess whether these numerical differences reflect treatment effects. Systemic inflammation commonly accompanies metabolic dysfunction in transition dairy cows, and serum HP and SAA are established biomarkers of systemic inflammatory status [34,35]. Extensive mobilization of adipose reserves and the resulting changes in circulating NEFA and BHBA concentrations are considered major contributors to this inflammatory response [36]. Earlier reports documented markedly higher serum HP and SAA concentrations in cows affected by fatty liver or ketosis than in healthy cows [37,38]. Although previous research has suggested anti-inflammatory effects of MEL [39], our findings support differences in the temporal profiles of SAA and HP rather than a sustained reduction in their circulating concentrations. Both markers showed significant treatment × time interactions, with numerical decreases from prepartum to 5 d postpartum in MEL cows and increases in CON cows. However, neither marker differed significantly between groups at any sampling time after Šídák adjustment. These results therefore suggest treatment-associated differences in inflammatory response patterns but do not establish that MEL consistently attenuated systemic inflammation throughout the transition period. Because the production and metabolism of NEFA and BHBA are closely associated with liver and adipose tissue function [40,41,42], transcriptomic analyses of liver tissue and sWAT were performed to further explore the tissue-specific molecular responses associated with prepartum MEL administration across the prepartum-to-postpartum transition.
4.1. Effects of MEL on the Postpartum Liver and sWAT
Direct comparisons at 5 d postpartum identified only five DEGs in each tissue, indicating limited detectable between-group differences at this time point. A single MEL dose was administered 14 ± 1 d before expected calving, whereas biopsies were collected at 5 d postpartum. Published bovine pharmacokinetic profiles in calves [43] and postpartum dairy cows [44] suggest that this interval may have limited detection of an acute drug-associated transcriptional response. However, MEL concentrations were not measured in this study, so exposure at biopsy remains uncertain. The small RNA-seq subset (six cows per group) may also have limited statistical power. The within-group longitudinal comparisons identified genes meeting the differential expression criteria in MEL but not CON cows, providing exploratory candidates for possible treatment-related responses during the transition period. These longitudinal gene sets address a different comparison and may also reflect physiological adaptation around calving.
4.2. Effects of MEL During the Transition Period
Exploratory enrichment analysis of genes identified only in the MEL within-group longitudinal comparisons highlighted biological processes and pathways related to inflammation and immune regulation. Fewer GO terms and KEGG pathways met Q < 0.05 in the liver than in sWAT. Among these pathways, negative regulation of monocyte chemotaxis was the most significantly enriched GO term (Q = 0.0123), involving two upregulated genes, DUSP1 and CCN3. During inflammatory responses, DUSP1 reduces chemokine expression, including that of C-X-C motif chemokine ligand 1 (CXCL1) and C-X-C motif chemokine ligand 2 (CXCL2) through the tristetraprolin (TTP)-dependent pathway, thereby weakening inflammatory responses [45]. Similarly, CCN3 decreases leukocyte adhesion to endothelial cells and inhibits activation of the NF-κB signaling pathway, which in turn limits monocyte recruitment [46]. Monocytes contribute to inflammation through cytokine and reactive oxygen species (ROS) production. The upregulation of DUSP1 and CCN3 may reflect altered regulation of monocyte recruitment during hepatic inflammation. Systemic inflammation further damages liver function by promoting hepatic accumulation of NEFA and infiltration of inflammatory cells [47]. AST is a well-recognized biomarker of hepatocellular injury and directly indicates the severity of liver damage [48]. GGT, which is predominantly expressed in the liver, kidneys, and pancreas, is also an important marker of hepatobiliary injury and is greatly increased during liver injury and tumor progression [49]. In addition, the serum GGT-to-platelet ratio has been suggested as a simple marker for hepatic inflammation among individuals with chronic hepatitis B [50]. Among dairy cows affected by ketosis, increased serum AST and GGT activities indicate hepatic injury and increased inflammatory cell infiltration [51,52]. The treatment-associated difference in AST temporal profiles may reflect altered hepatic adaptation during the transition period, whereas GGT showed no significant treatment × time interaction. Although the influence of MEL on hepatic injury has not previously been investigated in dairy cows, experimental evidence in mice has shown that MEL decreases serum AST activity [53]. Earlier work has further linked systemic inflammation in dairy cows to excessive hepatic activation of NF-κB and NLR Family Pyrin Domain Containing 3 (NLRP3) inflammasome signaling, which promotes liver injury and hepatic lipidosis [54]. In contrast, the transcriptomic data of the present study did not show significant regulation of the NF-κB or NLRP3 signaling pathways by MEL. Adipose tissue lipolysis is associated with an overabundance of ROS, which drives inflammation-related tissue remodeling [10]. Because dairy cows with high BCS undergo more severe adipose tissue mobilization throughout the periparturient interval, sWAT is regarded as an important contributor to systemic inflammation. In agreement with this view, genes identified only in the MEL longitudinal comparison in adipose tissue predominantly mapped to immune and inflammatory processes, suggesting a possible role for this tissue in responses to prepartum MEL.
Periparturient metabolic adaptation can affect the energy supply of immune cells through both direct and indirect mechanisms, which may compromise immune competence and heighten vulnerability to infectious diseases, including mastitis and endometritis. In the present study, most pathways enriched in sWAT were closely related to innate immune responses and antimicrobial defense. As primary cellular defenders against invading pathogens, polymorphonuclear neutrophils (PMNs) eliminate microorganisms mainly through ROS produced during the respiratory burst. The NADPH oxidase complex is required for respiratory burst activity and ROS generation and comprises the CYBB- and CYBA-encoded membrane components together with cytosolic components encoded by NCF1, NCF2, and NCF4 [55,56]. During the transition period, INS sensitivity is reduced in adipose tissue, liver, and skeletal muscle, resulting in impaired glucose uptake [57,58]. Excessive lipolysis releases NEFA that can impair PMN migration, phagocytosis, respiratory burst activity, and ROS production and may promote apoptosis [10]. The respiratory burst is highly energy dependent, and PMNs need sufficient adenosine triphosphate (ATP) production to sustain antimicrobial activity. However, glucose availability is commonly restricted at inflammatory sites [59]. Evidence from human studies further demonstrates that Toll-like receptor (TLR) activation increases glucose uptake by upregulating glucose transporters in neutrophils, thereby supporting cellular metabolism under nutrient-limited conditions [60,61]. Collectively, this evidence suggests that INS resistance, excessive lipolysis, and systemic inflammation may together limit the energy supply to PMNs and thereby contribute to immunosuppression throughout the periparturient interval. Supporting this interpretation, LeBlanc et al. reported that glucose deficiency, together with increased circulating NEFA and BHBA concentrations, impaired PMN function in dairy cows undergoing the transition period [62]. MEL treatment was associated with a different temporal profile of serum INS concentrations during the transition period. Serum INS concentrations alone do not demonstrate improved insulin sensitivity, which was not directly assessed in this study.
In the MEL within-group longitudinal comparison, NCF4, NCF2, CYBB, and CYBA, which are associated with respiratory burst and the NADPH oxidase complex, were significantly upregulated. The TLR-related genes CD180, LY96, TLR2, and UNC93B1 were also upregulated. The complex of CD180, also known as radioprotective 105 (RP105), and myeloid differentiation protein 1 (MD-1) can heterodimerize with the complex of Toll-like receptor 4 (TLR4) and LY96, also known as myeloid differentiation protein 2 (MD-2) and reduce lipopolysaccharide (LPS)-induced inflammatory signaling [63]. The concurrent upregulation of CD180 and LY96 may therefore reflect altered regulation of LPS-responsive signaling. In addition, UNC93B1 is an essential trafficking protein required for the proper intracellular localization and signaling of multiple TLRs, and dysfunction of UNC93B1 markedly weakens TLR-mediated innate immune responses [64]. The coordinated expression changes in NADPH oxidase- and TLR-related genes suggest that MEL may influence neutrophil metabolic and antimicrobial responses. Changes in CD180, LY96, and UNC93B1 expression may also reflect altered regulation of pathogen recognition and inflammatory signaling.
In addition to neutrophil-related pathways, sWAT showed significant enrichment of pathways in B-cell activation (B-cell receptor signaling pathway, Q = 0.0034; B-cell activation, Q = 0.0293), natural killer cell-mediated cytotoxicity (Q = 0.0010), leukocyte transendothelial migration, chemokine signaling pathway, and complement and coagulation cascades. Nearly all genes enriched in these pathways were significantly upregulated. Among them, FCRL1 positively regulates B-cell activation and immune function [65,66], whereas BANK1 participates in innate immune signaling in B cells [67]. After antigen recognition, the downstream kinase PRKCB initiates B-cell receptor signaling and promotes B-cell activation [68]. In addition, CR2 enhances humoral immunity and contributes to immune tolerance through complement-mediated regulation of B-cell function [69]. In the present study, CR2, PRKCB, FCRL1, and BANK1 were significantly upregulated in the MEL within-group longitudinal comparison. Earlier work indicates that elevated concentrations of cortisol and other glucocorticoids throughout the transition period suppress B-cell differentiation and lymphocyte proliferation, thereby contributing to immunosuppression in dairy cows [70].
Taken together, the biomarker temporal patterns and transcriptomic findings suggest that prepartum MEL may modulate inflammatory and immune adaptation during the transition period. These interpretations remain exploratory; potential effects on respiratory burst activity, neutrophil bactericidal capacity, and B-cell or natural killer cell function require direct functional validation.
The biochemical and transcriptomic analyses were restricted to a randomly selected subset of 12 cows (six per group), whereas clinical and production outcomes were summarized for the full 72-cow cohort. The small mechanistic subset limits statistical power and the generalizability of the molecular findings. Accordingly, the transcriptomic results should be interpreted as exploratory evidence of treatment-associated molecular responses rather than definitive evidence of the underlying mechanisms and require confirmation in larger studies. A gene meeting the differential expression criteria in one group but not the other does not establish a significant difference in longitudinal change, because Venn analysis is not a treatment × time interaction test. The absence of experimental verification of amplification efficiencies and reference-gene stability warrants caution when interpreting RT-qPCR fold-change estimates.
5. Conclusions
A single subcutaneous dose of MEL (0.5 mg/kg body weight) administered 14 ± 1 days before expected calving was associated with different temporal profiles of NEFA, AST, SAA, HP, and INS during the transition period. Longitudinal transcriptomic changes were consistent with altered regulation of hepatic inflammation and innate immune signaling in sWAT, whereas direct between-group transcriptomic differences at 5 days postpartum were limited. Descriptively, MEL-treated cows had fewer postpartum disease events and a higher pregnancy proportion, while milk yield was similar between groups. Because these clinical outcomes were not subjected to inferential testing, they should be regarded as exploratory. Larger, adequately powered studies are required to determine whether prepartum MEL improves health and reproductive outcomes and whether additional postpartum dosing provides further benefit.
Supplementary Materials
Supplementary data associated with this article are available at https://data.mendeley.com/datasets/bzdd7xs8tv/3 (accessed on 12 November 2026) (Version 3; https://doi.org/10.17632/bzdd7xs8tv.3).
Author Contributions
Conceptualization, J.C.; investigation, Y.G., Y.C., X.L. and P.H.; writing—original draft preparation, Y.G.; writing—review and editing, Y.G. and J.C.; funding acquisition, J.C. and Y.Z. All authors have read and agreed to the published version of the manuscript.
Funding
This research was funded by the earmarked fund for CARS36.
Institutional Review Board Statement
All animal procedures were conducted at Hebei Shounong Modern Agricultural Technology Co., Ltd. with approval from the Animal Ethics Committee of China Agricultural University (approval no. AW80215202-2-03, approval date: 8 December 2025).
Informed Consent Statement
Informed consent was obtained from all subjects involved in the study.
Data Availability Statement
The raw sequencing data are publicly available in the GSA under accession CRA045141 (https://ngdc.cncb.ac.cn/gsa, the data will be released on 31 December 2026).
Acknowledgments
The authors thank the veterinarian of Hebei Shounong Modern Agricultural Technology Co., Ltd. (Dingzhou, China) for skilled assistance.
Conflicts of Interest
The authors declare no conflicts of interest.
Abbreviations
ANOVA = Analysis of variance; AST = Aspartate aminotransferase; ATP = Adenosine triphosphate; BANK1 = B Cell Scaffold Protein with Ankyrin Repeats 1; BCS = Body condition score; BHBA = β-Hydroxybutyrate; bp = Base pairs; CCN3 = Cellular Communication Network Factor 3; CD180 = CD180 Molecule; cDNA = Complementary deoxyribonucleic acid; CMT = California mastitis test; CON = Control; CR2 = Complement Receptor Type 2; Ct = Cycle threshold; CXCL1 = C-X-C Motif Chemokine Ligand 1; CXCL2 = C-X-C Motif Chemokine Ligand 2; CYBA = Cytochrome b-245 Alpha Chain; CYBB = Cytochrome b-245 Beta Chain; DEGs = Differentially expressed genes; DMI = Dry matter intake; DNA = Deoxyribonucleic acid; DUSP1 = Dual Specificity Phosphatase 1; dUTP = Deoxyuridine triphosphate; FC = Fold change; FCRL1 = Fc Receptor Like 1; FDR = False discovery rate; FPKM = Fragments per kilobase of transcript per million mapped reads; GAPDH = Glyceraldehyde-3-phosphate dehydrogenase; GGT = γ-Glutamyl transferase; GO = Gene Ontology; GSA = Genome Sequence Archive; HP = Haptoglobin; IFN = Interferon; IGF1 = Insulin-like growth factor 1; INS = Insulin; KEGG = Kyoto Encyclopedia of Genes and Genomes; LPS = Lipopolysaccharide; LY96 = Lymphocyte Antigen 96; MAPK = Mitogen-activated protein kinase; MD-1 = Myeloid differentiation protein 1; MD-2 = Myeloid differentiation protein 2; MEL = Meloxicam; mRNA = Messenger RNA; NAD(P)H = Reduced nicotinamide adenine dinucleotide (phosphate); NADPH = Reduced nicotinamide adenine dinucleotide phosphate; NCF1 = Neutrophil Cytosolic Factor 1; NCF2 = Neutrophil Cytosolic Factor 2; NCF4 = Neutrophil Cytosolic Factor 4; NEB = Negative energy balance; NEFA = Non-esterified fatty acids; NF-κB = Nuclear Factor Kappa B; NGDC = National Genomics Data Center; NLRP3 = NLR Family Pyrin Domain Containing 3; NSAIDs = Non-steroidal anti-inflammatory drugs; OD260/OD280 = Ratio of optical density at 260 nm to that at 280 nm; PC1 = Principal component 1; PCA = Principal component analysis; PMNs = Polymorphonuclear neutrophils; PP = Postpartum; PPAR = Peroxisome proliferator-activated receptor; PPRE = Prepartum; PRKCB = Protein Kinase C Beta; RIN = RNA integrity number; RNA = Ribonucleic acid; RNA-seq = RNA sequencing; RNase H = Ribonuclease H; ROS = Reactive oxygen species; RP105 = Radioprotective 105; RPS9 = Ribosomal protein S9; RT-qPCR = Real-time quantitative polymerase chain reaction; SAA = Serum amyloid A; SEM = Standard error of the mean; sWAT = subcutaneous white adipose tissue; TG = Triglyceride; TLR = Toll-like receptor; TLR2 = Toll Like Receptor 2; TLR4 = Toll-like receptor 4; TMR = Total mixed ration; TRP = Transient receptor potential; TTP = Tristetraprolin; UDG = Uracil-DNA glycosylase; UNC93B1 = Unc-93 Homolog B1.
References
- Mann, S.; Nydam, D.V.; Abuelo, A.; Leal Yepes, F.A.; Overton, T.R.; Wakshlag, J.J. Insulin signaling, inflammation, and lipolysis in subcutaneous adipose tissue of transition dairy cows either overfed energy during the prepartum period or fed a controlled-energy diet. J. Dairy Sci. 2016, 99, 6737–6752. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Roche, J.R.; Meier, S.; Heiser, A.; Mitchell, M.D.; Walker, C.G.; Crookenden, M.A.; Riboni, M.V.; Loor, J.J.; Kay, J.K. Effects of precalving body condition score and prepartum feeding level on production, reproduction, and health parameters in pasture-based transition dairy cows. J. Dairy Sci. 2015, 98, 7164–7182. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Shi, X.; Li, X.; Li, D.; Li, Y.; Song, Y.; Deng, Q.; Wang, J.; Zhang, Y.; Ding, H.; Yin, L.; et al. β-Hydroxybutyrate activates the NF-κB signaling pathway to promote the expression of pro-inflammatory factors in calf hepatocytes. Cell. Physiol. Biochem. 2014, 33, 920–932. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Bradford, B.J.; Yuan, K.; Farney, J.K.; Mamedova, L.K.; Carpenter, A.J. Invited review: Inflammation during the transition to lactation: New adventures with an old flame. J. Dairy Sci. 2015, 98, 6631–6650. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Pascottini, O.B.; Leroy, J.; Opsomer, G. Metabolic Stress in the Transition Period of Dairy Cows: Focusing on the Prepartum Period. Animals 2020, 10, 1419. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kuhla, B. Review: Pro-inflammatory cytokines and hypothalamic inflammation: Implications for insufficient feed intake of transition dairy cows. Animal 2020, 14, s65–s77. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Carretta, M.D.; Barría, Y.; Borquez, K.; Urra, B.; Rivera, A.; Alarcón, P.; Hidalgo, M.A.; Burgos, R.A. β-hydroxybutyrate and hydroxycarboxylic acid receptor 2 agonists activate the AKT, ERK and AMPK pathways, which are involved in bovine neutrophil chemotaxis. Sci. Rep. 2020, 10, 12491. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Vanacker, N.; Hooper, H.B.; Blouin, R.; Lacasse, P. Effect of intravenous lipid infusion on biomarkers of insulin resistance and immune functions of dry and nonpregnant dairy cows. J. Dairy Sci. 2023, 106, 2113–2123. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Gu, F.; Zhu, S.; Tang, Y.; Liu, X.; Jia, M.; Malmuthuge, N.; Valencak, T.G.; McFadden, J.W.; Liu, J.X.; Sun, H.Z. Gut microbiome is linked to functions of peripheral immune cells in transition cows during excessive lipolysis. Microbiome 2023, 11, 40. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Contreras, G.A.; Strieder-Barboza, C.; De Koster, J. Symposium review: Modulating adipose tissue lipolysis and remodeling to improve immune function during the transition period and early lactation of dairy cows. J. Dairy Sci. 2018, 101, 2737–2752. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zerbe, H.; Schneider, N.; Leibold, W.; Wensing, T.; Kruip, T.A.; Schuberth, H.J. Altered functional and immunophenotypical properties of neutrophilic granulocytes in postpartum cows associated with fatty liver. Theriogenology 2000, 54, 771–786. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Crookenden, M.A.; Moyes, K.M.; Kuhn-Sherlock, B.; Lehnert, K.; Walker, C.G.; Loor, J.J.; Mitchell, M.D.; Murray, A.; Dukkipati, V.S.R.; Vailati-Riboni, M.; et al. Transcriptomic analysis of circulating neutrophils in metabolically stressed peripartal grazing dairy cows. J. Dairy Sci. 2019, 102, 7408–7420. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Dai, L.; Liu, Z.; Guo, L.; Chai, Y.; Yang, Y.; Wang, Y.; Ma, Y.; Shi, C.; Zhang, W. Multi-Tissue Transcriptome Study of Innate Immune Gene Expression Profiling Reveals Negative Energy Balance Altered the Defense and Promoted System Inflammation of Dairy Cows. Vet. Sci. 2023, 10, 107. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Chabanenko, D.; Zhelavskyi, M.; Skliarov, P.; Gutyj, B.; Wrzecińska, M.; Lone, F.; Rana, S.; Khmeleva, O.V.; Mylostyvyi, R. Postpartum complications in cows: Diagnosis, treatment, prevention. Ukr. J. Vet. Agric. Sci. 2024, 7, 60–67. [Google Scholar] [CrossRef] [Scilit]
- Bruinjé, T.C.; LeBlanc, S.J. Invited review: Inflammation and health in the transition period influence reproductive function in dairy cows. Animals 2025, 15, 633. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Gilbert, R.O. Symposium review: Mechanisms of disruption of fertility by infectious diseases of the reproductive tract. J. Dairy Sci. 2019, 102, 3754–3765. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Carpenter, A.J.; Ylioja, C.M.; Vargas, C.F.; Mamedova, L.K.; Mendonça, L.G.; Coetzee, J.F.; Hollis, L.C.; Gehring, R.; Bradford, B.J. Hot topic: Early postpartum treatment of commercial dairy cows with nonsteroidal antiinflammatory drugs increases whole-lactation milk yield. J. Dairy Sci. 2016, 99, 672–679. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Qi, J.; Fang, J.; Huang, F.; Li, Z.; Kumbhar, M.A.; Guo, H.; Ren, Z.; Geng, Y.; Deng, J.; Zuo, Z. Effects of meloxicam on the welfare of Holstein calves from 6 weeks to 6 months old undergoing amputation dehorning. J. Dairy Sci. 2024, 107, 6065–6078. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Cysewski, P. Intermolecular interaction as a direct measure of water solubility advantage of meloxicam cocrystalized with carboxylic acids. J. Mol. Model. 2018, 24, 112. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Qi, J.; Fang, J.; Huang, F.; Li, Z.; Kumbhar, M.A.; Cui, H.; Guo, H.; Shen, L.; Ren, Z.; Geng, Y.; et al. A clinical trial on the welfare effects of administering meloxicam to 10 to 21 day dairy calves following caustic paste disbudding. J. Anim. Sci. 2023, 101, skad266. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Theurer, M.E.; White, B.J.; Coetzee, J.F.; Edwards, L.N.; Mosher, R.A.; Cull, C.A. Assessment of behavioral changes associated with oral meloxicam administration at time of dehorning in calves using a remote triangulation device and accelerometers. BMC Vet. Res. 2012, 8, 48. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Caldeira, M.O.; Bruckmaier, R.M.; Wellnitz, O. Effects of local or systemic administration of meloxicam on mammary gland inflammatory responses to lipopolysaccharide-induced mastitis in dairy cows. J. Dairy Sci. 2021, 104, 1039–1052. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Liu, K.; Qiu, S.; Fang, L.; Cui, L.; Dong, J.; Guo, L.; Meng, X.; Li, J.; Wang, H. The Effect of Meloxicam on Inflammatory Response and Oxidative Stress Induced by Klebsiella pneumoniae in Bovine Mammary Epithelial Cells. Vet. Sci. 2024, 11, 607. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Fitzpatrick, C.E.; Chapinal, N.; Petersson-Wolfe, C.S.; DeVries, T.J.; Kelton, D.F.; Duffield, T.F.; Leslie, K.E. The effect of meloxicam on pain sensitivity, rumination time, and clinical signs in dairy cows with endotoxin-induced clinical mastitis. J. Dairy Sci. 2013, 96, 2847–2856. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Swartz, T.H.; Schramm, H.H.; Bewley, J.M.; Wood, C.M.; Leslie, K.E.; Petersson-Wolfe, C.S. Meloxicam administration either prior to or after parturition: Effects on behavior, health, and production in dairy cows. J. Dairy Sci. 2018, 101, 10151–10167. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Guo, Y.; Wei, Z.; Zhang, Y.; Ma, C.; Cao, J. Transcriptomic analysis reveals metabolic changes in the liver, subcutaneous adipose, and mammary gland tissues during the process of conjugated linoleic acid-induced milk fat depression in dairy cows. J. Dairy Sci. 2026, 109, 2023–2038. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Mortazavi, A.; Williams, B.A.; McCue, K.; Schaeffer, L.; Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 2008, 5, 621–628. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Pertea, M.; Pertea, G.M.; Antonescu, C.M.; Chang, T.C.; Mendell, J.T.; Salzberg, S.L. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat. Biotechnol. 2015, 33, 290–295. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Pertea, G.; Pertea, M. GFF utilities: GffRead and GffCompare. F1000Research 2020, 9, 304. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Love, M.I.; Huber, W.; Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014, 15, 550. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Khan, M.J.; Hosseini, A.; Burrell, S.; Rocco, S.M.; McNamara, J.P.; Loor, J.J. Change in subcutaneous adipose tissue metabolism and gene network expression during the transition period in dairy cows, including differences due to sire genetic merit. J. Dairy Sci. 2013, 96, 2171–2182. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Janovick-Guretzky, N.A.; Dann, H.M.; Carlson, D.B.; Murphy, M.R.; Loor, J.J.; Drackley, J.K. Housekeeping gene expression in bovine liver is affected by physiological state, feed intake, and dietary treatment. J. Dairy Sci. 2007, 90, 2246–2252. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Shock, D.A.; Renaud, D.L.; Roche, S.M.; Poliquin, R.; Thomson, R.; Olson, M.E. Evaluating the impact of meloxicam oral suspension administered at parturition on subsequent production, health, and culling in dairy cows: A randomized clinical field trial. PLoS ONE 2018, 13, e0209236. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Humblet, M.F.; Guyot, H.; Boudry, B.; Mbayahi, F.; Hanzen, C.; Rollin, F.; Godeau, J.M. Relationship between haptoglobin, serum amyloid A, and clinical status in a survey of dairy herds during a 6-month period. Vet. Clin. Pathol. 2006, 35, 188–193. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Jermann, P.M.; Wagner, L.A.; Fritsche, D.; Gross, J.J.; Wellnitz, O.; Bruckmaier, R.M. Acute phase reaction to lipopolysaccharide-induced mastitis in early lactation dairy cows fed nitrogenic, glucogenic, or lipogenic diets. J. Dairy Sci. 2023, 106, 9879–9891. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zhang, M.Q.; Heirbaut, S.; Hertogs, K.; Girma, M.; Geerinckx, K.; Stevens, E.; Aernouts, B.; De Neve, N.; Fievez, V. Periparturient oxidative and inflammatory status and their relation to energy metabolism and performance in transition dairy cows. J. Dairy Sci. 2025, 108, 13872–13889. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Ametaj, B.N.; Bradford, B.J.; Bobe, G.; Nafikov, R.A.; Lu, Y.; Young, J.W.; Beitz, D.C. Strong relationships between mediators of the acute phase response and fatty liver in dairy cows. Can. J. Anim. Sci. 2005, 85, 165–175. [Google Scholar] [CrossRef] [Scilit]
- Abuajamieh, M.; Kvidera, S.K.; Fernandez, M.V.; Nayeri, A.; Upah, N.C.; Nolan, E.A.; Lei, S.M.; DeFrain, J.M.; Green, H.B.; Schoenberg, K.M.; et al. Inflammatory biomarkers are associated with ketosis in periparturient Holstein cows. Res. Vet. Sci. 2016, 109, 81–85. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Crookenden, M.A.; Lake, A.V.R.; Burke, C.R.; Pratt, J.T.; Mitchell, M.D.; Phyn, C.V.C.; Roche, J.R.; Heiser, A. Effect of nonsteroidal anti-inflammatory drugs on the inflammatory response of bovine endometrial epithelial cells in vitro. J. Dairy Sci. 2023, 106, 2651–2666. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Li, J.; Zhao, C.; Qi, D.; Kong, F.; Liu, M.; Gao, J.; Li, E.; Gao, W.; Du, X.; Song, Y.; et al. The role of glutathione S-transferase mu 2 in mitigating fatty acid-induced hepatic inflammation in dairy cows. J. Dairy Sci. 2025, 108, 4149–4162. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Saremi, B.; Mielenz, M.; Rahman, M.M.; Hosseini, A.; Kopp, C.; Dänicke, S.; Ceciliani, F.; Sauerwein, H. Hepatic and extrahepatic expression of serum amyloid A3 during lactation in dairy cows. J. Dairy Sci. 2013, 96, 6944–6954. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sivinski, S.E.; Meier, K.E.; Mamedova, L.K.; Saylor, B.A.; Shaffer, J.E.; Sauls-Hiesterman, J.A.; Yoon, I.; Bradford, B.J. Effect of Saccharomyces cerevisiae fermentation product on oxidative status, inflammation, and immune response in transition dairy cattle. J. Dairy Sci. 2022, 105, 8850–8865. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Coetzee, J.F.; KuKanich, B.; Mosher, R.; Allen, P.S. Pharmacokinetics of intravenous and oral meloxicam in ruminant calves. Vet. Ther. 2009, 10, E1–E8. [Google Scholar] [PubMed]
- Shock, D.; Roche, S.; Olson, M. A comparative pharmacokinetic analysis of oral and subcutaneous meloxicam administered to postpartum dairy cows. Vet. Sci. 2019, 6, 73. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Smallie, T.; Ross, E.A.; Ammit, A.J.; Cunliffe, H.E.; Tang, T.; Rosner, D.R.; Ridley, M.L.; Buckley, C.D.; Saklatvala, J.; Dean, J.L.; et al. Dual-specificity phosphatase 1 and tristetraprolin cooperate to regulate macrophage responses to lipopolysaccharide. J. Immunol. 2015, 195, 277–288. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Lin, Z.; Natesan, V.; Shi, H.; Hamik, A.; Kawanami, D.; Hao, C.; Mahabaleshwar, G.H.; Wang, W.; Jin, Z.G.; Atkins, G.B.; et al. A novel role of CCN3 in regulating endothelial inflammation. J. Cell Commun. Signal. 2010, 4, 141–153. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Fang, Z.; Li, X.; Wang, S.; Jiang, Q.; Loor, J.J.; Jiang, X.; Ju, L.; Yu, H.; Shen, T.; Chen, M.; et al. Overactivation of hepatic mechanistic target of rapamycin kinase complex 1 (mTORC1) is associated with low transcriptional activity of transcription factor EB and lysosomal dysfunction in dairy cows with clinical ketosis. J. Dairy Sci. 2022, 105, 4520–4533. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Guyatt, G.H.; Oxman, A.D.; Vist, G.E.; Kunz, R.; Falck-Ytter, Y.; Alonso-Coello, P.; Schünemann, H.J. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008, 336, 924–926. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Veshkini, A.; Dengler, F.; Bachmann, L.; Liermann, W.; Helm, C.; Ulrich, R.; Delling, C.; Kühn, C.; Hammon, H.M. Cryptosporidium parvum infection alters the intestinal mucosa transcriptome in neonatal calves: Implications for immune function. Front. Immunol. 2024, 15, 1351427. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Wang, J.; Xia, J.; Zhang, R.; Yan, X.; Yang, Y.; Zhao, X.; Chang, H.; Wang, G.; Chen, G.; Liu, Y.; et al. A novel index using routine clinical parameters for predicting significant liver inflammation in chronic hepatitis B. J. Viral Hepat. 2018, 25, 1151–1160. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Liu, M.; Gu, J.; Zhao, C.; Li, J.; Kong, F.; Du, X.; Qi, D.; Li, E.; Gao, J.; Du, X.; et al. Hepatocyte necroptosis is associated with liver damage in dairy cows with ketosis. J. Dairy Sci. 2025, 108, 8844–8858. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zhao, C.; Li, J.; Liu, M.; Chen, L.; Zhu, Y.; Gao, W.; Du, X.; Song, Y.; Liu, G.; Lei, L.; et al. Inhibition of cluster antigen 36 protects against fatty acid-induced lipid accumulation, oxidative stress, and inflammation in bovine hepatocytes. J. Dairy Sci. 2023, 106, 9186–9199. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Xia, H.; He, Q.; Wang, H.; Wang, Y.; Yang, Y.; Li, Y.; Zhang, J.; Chen, Z.; Yang, J. Treatment with either COX-2 inhibitor or 5-LOX inhibitor causes no compensation between COX-2 pathway and 5-LOX pathway in chronic aluminum overload-induced liver injury in rats. Fundam. Clin. Pharmacol. 2019, 33, 535–543. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Shen, T.; Li, X.; Loor, J.J.; Zhu, Y.; Du, X.; Wang, X.; Xing, D.; Shi, Z.; Fang, Z.; Li, X.; et al. Hepatic nuclear factor kappa B signaling pathway and NLR family pyrin domain containing 3 inflammasome is over-activated in ketotic dairy cows. J. Dairy Sci. 2019, 102, 10554–10563. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Vermot, A.; Petit-Härtlein, I.; Smith, S.M.E.; Fieschi, F. NADPH oxidases (NOX): An overview from discovery, molecular mechanisms to physiology and pathology. Antioxidants 2021, 10, 890. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Begum, R.; Thota, S.; Abdulkadir, A.; Kaur, G.; Bagam, P.; Batra, S. NADPH oxidase family proteins: Signaling dynamics to disease management. Cell. Mol. Immunol. 2022, 19, 660–686. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Kaske, M.; Elmahdi, B.; von Engelhardt, W.; Sallmann, H.P. Insulin responsiveness of sheep, ponies, miniature pigs and camels: Results of hyperinsulinemic clamps using porcine insulin. J. Comp. Physiol. B 2001, 171, 549–556. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Bell, A.W.; Bauman, D.E. Adaptations of glucose metabolism during pregnancy and lactation. J. Mammary Gland Biol. Neoplasia 1997, 2, 265–278. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Watts, E.R.; Howden, A.J.; Morrison, T.; Sadiku, P.; Hukelmann, J.; von Kriegsheim, A.; Ghesquiere, B.; Murphy, F.; Mirchandani, A.S.; Humphries, D.C.; et al. Hypoxia drives murine neutrophil protein scavenging to maintain central carbon metabolism. J. Clin. Investig. 2021, 131, e134073. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Maratou, E.; Dimitriadis, G.; Kollias, A.; Boutati, E.; Lambadiari, V.; Mitrou, P.; Raptis, S.A. Glucose transporter expression on the plasma membrane of resting and activated white blood cells. Eur. J. Clin. Investig. 2007, 37, 282–290. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Morrison, T.; Watts, E.R.; Sadiku, P.; Walmsley, S.R. The emerging role for metabolism in fueling neutrophilic inflammation. Immunol. Rev. 2023, 314, 427–441. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- LeBlanc, S.J. Review: Relationships between metabolism and neutrophil function in dairy cows in the peripartum period. Animal 2020, 14, s44–s54. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Yoon, S.I.; Hong, M.; Wilson, I.A. An unusual dimeric structure and assembly for TLR4 regulator RP105-MD-1. Nat. Struct. Mol. Biol. 2011, 18, 1028–1035. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Tucker, M.H.; Yu, W.; Menden, H.; Xia, S.; Schreck, C.F.; Gibson, M.; Louiselle, D.; Pastinen, T.; Raje, N.; Sampath, V. IRF7 and UNC93B1 variants in an infant with recurrent herpes simplex virus infection. J. Clin. Investig. 2023, 133, e154016. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Zhao, X.; Xie, H.; Zhao, M.; Ahsan, A.; Li, X.; Wang, F.; Yi, J.; Yang, Z.; Wu, C.; Raman, I.; et al. Fc receptor-like 1 intrinsically recruits c-Abl to enhance B cell activation and function. Sci. Adv. 2019, 5, eaaw0315. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Yousefi, Z.; Sharifzadeh, S.; Yar-Ahmadi, V.; Andalib, A.; Eskandari, N. Fc receptor-like 1 as a promising target for immunotherapeutic interventions of B-cell-related disorders. Biomark. Insights 2019, 14, 1177271919882351. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Georg, I.; Díaz-Barreiro, A.; Morell, M.; Pey, A.L.; Alarcón-Riquelme, M.E. BANK1 interacts with TRAF6 and MyD88 in innate immune signaling in B cells. Cell. Mol. Immunol. 2020, 17, 954–965. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Sabat, R.; Šimaitė, D.; Gudjonsson, J.E.; Brembach, T.C.; Witte, K.; Krause, T.; Kokolakis, G.; Bartnik, E.; Nikolaou, C.; Rill, N.; et al. Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa. J. Allergy Clin. Immunol. 2023, 151, 1015–1026. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Holers, V.M.; Kulik, L. Complement receptor 2, natural antibodies and innate immunity: Inter-relationships in B cell selection and activation. Mol. Immunol. 2007, 44, 64–72. [Google Scholar] [CrossRef] [Scilit] [PubMed]
- Oray, M.; Abu Samra, K.; Ebrahimiadib, N.; Meese, H.; Foster, C.S. Long-term side effects of glucocorticoids. Expert Opin. Drug Saf. 2016, 15, 457–465. [Google Scholar] [CrossRef] [Scilit] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.










